↓ Skip to main content

Insights into maternal and neonatal anti-Ro/SSA antibodies: implications on pregnancy and neonatal health

Overview of attention for article published in Frontiers in Lupus, May 2024
Altmetric Badge

Mentioned by

twitter
1 X user
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Insights into maternal and neonatal anti-Ro/SSA antibodies: implications on pregnancy and neonatal health
Published in
Frontiers in Lupus, May 2024
DOI 10.3389/flupu.2024.1358121
Authors

Samar Al Emadi, Eman Satti, Nawal Hadwan

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2024.
All research outputs
#23,339,732
of 26,009,886 outputs
Outputs from Frontiers in Lupus
#5
of 5 outputs
Outputs of similar age
#119,442
of 150,039 outputs
Outputs of similar age from Frontiers in Lupus
#2
of 2 outputs
Altmetric has tracked 26,009,886 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5 research outputs from this source. They receive a mean Attention Score of 1.1. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 150,039 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.